Neve Gordon
#17,008
Most Influential Person Now
Israeli political scientist
Neve Gordon's AcademicInfluence.com Rankings
Neve Gordonpolitical-science Degrees
Political Science
#591
World Rank
#768
Historical Rank
Public Policy
#720
World Rank
#773
Historical Rank
Download Badge
Political Science
Neve Gordon's Degrees
- PhD Political Science University of California, Berkeley
- Masters Political Science University of California, Berkeley
Why Is Neve Gordon Influential?
(Suggest an Edit or Addition)According to Wikipedia, Neve Gordon is an Israeli professor and academic. He is a professor of international law and human rights at Queen Mary University of London and writes on issues relating to the Israeli–Palestinian conflict and human rights. He used to teach at Ben-Gurion University of the Negev. A member of Academia for Equality, an organization working to promote democratization, equality and access to higher education for all communities living in Israel.
Neve Gordon's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Factors Associated With Early Presentation of Acute Stroke (1993) (141)
- Gender Differences in the Behavioral Manifestations of Alzheimer's Disease (1996) (113)
- Cognitive and motor impairments predict functional declines in patients with vascular dementia (2002) (95)
- Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS (2016) (87)
- Relative contributions of the cerebellar vermis and prefrontal lobe volumes on cognitive function across the adult lifespan (2009) (69)
- A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non–Small Cell Lung Cancer (2017) (68)
- Trajectories of Injectable Cancer Drug Costs After Launch in the United States. (2017) (63)
- The relationship of subcortical MRI hyperintensities and brain volume to cognitive function in vascular dementia (2002) (58)
- Behavioral problems as predictors of functional abilities of vascular dementia patients. (2002) (55)
- Cognitive and neurologic predictors of functional impairment in vascular dementia. (2003) (55)
- Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma. (2017) (53)
- Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma (2017) (52)
- Cancer of the colon and rectum: Potential effects of sex-age interactions on incidence and outcome (2013) (49)
- Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer. (2018) (46)
- Cognitive-behavioral group treatment for disabling headache. (2004) (46)
- Rates of decline distinguish Alzheimer's disease and mild cognitive impairment relative to normal aging: integrating cognition and brain function. (2007) (44)
- Cognitive predictors of functional decline in vascular dementia (2006) (43)
- Long-Term Citicoline (Cytidine Diphosphate Choline) Use in Patients with Vascular Dementia: Neuroimaging and Neuropsychological Outcomes (2003) (40)
- Dementia Rating Scale Performance: A Comparison of Vascular and Alzheimer's Dementia (2000) (36)
- Executive function and magnetic resonance imaging subcortical hyperintensities in vascular dementia. (2001) (36)
- Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study (2012) (30)
- RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients (2017) (25)
- The Global Deterioration Scale: Relationships to Neuropsychological Performance and Activities of Daily Living in Patients with Vascular Dementia (2002) (25)
- The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United States (2019) (21)
- Performance on the Hooper Visual Organizational Test in patients diagnosed with subcortical vascular dementia: relation to naming performance. (2001) (21)
- Progressive morphometric and cognitive changes in vascular dementia. (2005) (19)
- Performance on the Mattis Dementia Rating Scale in Patients with Vascular Dementia: Relationships to Neuroimaging Findings (2001) (18)
- Dementia Severity and Pattern of Cognitive Performance in Vascular Dementia (2001) (18)
- The cost and value of cancer drugs – are new innovations outpacing our ability to pay? (2016) (15)
- Electroconvulsive Therapy in Parkinson's Disease: A Report on Five Cases. (1992) (15)
- Single Photon Emission Computed Tomography, Magnetic Resonance Imaging Hyperintensity, and Cognitive Impairments in Patients With Vascular Dementia (2001) (14)
- Young-onset gastric cancer and Epstein–Barr Virus (EBV) – a major player in the pathogenesis? (2020) (14)
- Neuroimaging Correlates of Dementia Rating Scale Performance at Baseline and 12-Month Follow-up among Patients with Vascular Dementia (2003) (11)
- Cognitive and functional status in two subtypes of vascular dementia. (2000) (10)
- The addition of cetuximab to preoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma is associated with high rate of long term survival: Mature results from a prospective phase Ib/II trial. (2019) (9)
- The serial position effect in mild and moderately severe vascular dementia (2002) (8)
- A real-world analysis of cancer drug wastage due to oversized vials. (2018) (8)
- Subvocal articulatory rehearsal during verbal working memory in multiple sclerosis (2010) (8)
- The combination of docetaxel, cisplatin, and 5-fluorouracil in advanced gastric cancer: a single-institution experience (2012) (7)
- Sensitivity of the Dementia Rating Scale in Vascular Dementia: Comparison between Two Sets of Criteria to Define Cognitive Impairment (2003) (7)
- Brain metastasis in gastroesophageal adenocarcinoma and HER2 status (2018) (6)
- The Financial Impact of Fractionation Scheme and Treatment Planning Method for Rectal Cancer in the United States. (2019) (6)
- Next‐generation sequencing in salivary gland carcinoma: Targetable alterations lead to a therapeutic advantage—Multicenter experience (2019) (6)
- Early Postoperative 18F-FDG PET/CT in High-Risk Stage III Colorectal Cancer (2015) (5)
- History of cluster headache (2005) (4)
- A phamacoeconomic analysis of personalized dosing versus fixed dosing of pembrolizumab in first-line PD-L1 positive non-small cell lung cancer. (2017) (4)
- ReCAP: Perspectives of Patients, Caregivers, and Medical Staff on Greetings in Oncology Practice: A Prospective Survey. (2016) (4)
- Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single Center Experience (2016) (4)
- A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer (2016) (4)
- Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors (2021) (3)
- Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage? (2021) (3)
- Factors Affecting Communication Patterns between Oncology Staff and Family Members of Deceased Patients: A Cross-Sectional Study (2016) (3)
- Early prediction of pathological complete response (pCR) of rectal cancer after 1 week of preoperative radiochemotherapy (RCT) using positron emission computererized tomography (PET-CT) imaging. (2011) (3)
- Price trajectory of individual cancer drugs following launch. (2016) (3)
- Early PET‐CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective study (2018) (3)
- Weekly docetaxel and cisplatin with capecitabine and bevacizumab (AVDCX) in patients with advanced esophagogastric cancer: Results of a phase Ib/II study. (2013) (2)
- Fractionation scheme and treatment planning method for early glottic cancer in the United States: Economic impact of different medical decisions (2020) (2)
- Factors Associated With Off-Label Oncology Prescriptions: The Role of Cost and Financing in a Universal Healthcare System (2021) (2)
- Clinical features of migraine and other headache disorders. (2014) (2)
- Cost-effectiveness of nivolumab in advanced renal cell carcinoma. (2017) (1)
- FDG-PET/CT in small cell lung cancer (SCLC): A value analysis. (2016) (1)
- Price trajectories assessment for Medicare Part B generic anti-cancer drugs. (2017) (1)
- Esophageal Cancer in Israel has Unique Clinico-Pathological Features: A Retrospective Study (2017) (1)
- First line treatment of metastatic colorectal cancer: Are clinical trial results reproducible in real-life practice? (2018) (0)
- Anti-Cancer Treatments in Elderly (≥75 Years Old) Patients: A Retrospective Analysis. (2014) (0)
- Factors affecting communication patterns between oncology staff and bereaved families: A cross-sectional study. (2014) (0)
- The Immerging Role of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma - A Case Series (2016) (0)
- Early prediction of residual disease after neoadjuvant chemoradiotherapy and cetuximab for locally advanced esophageal cancer using 18F-FDG PET-CT imaging: a prospective cohort study (2022) (0)
- The Influence Of Price Regulation Method On Price Trajectory – Assessment Of Cancer Drug Prices In Usa, The Uk And Israel (2016) (0)
- Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study (2012) (0)
- Young-onset gastric cancer and Epstein–Barr Virus (EBV) – a major player in the pathogenesis? (2020) (0)
- PO-1238 Volumetric modulated arc therapy is superior to intensity modulated radiotherapy for liver sparing in stereotactic body radiotherapy for hepatocellular carcinoma (2021) (0)
- Prospects of off-label (OL) drug use in oncology: Identifying predicting variables for registration and universal healthcare reimbursement. (2021) (0)
- Factors associated with off-label (OL) drug use in oncology: The role of cost and financing in a universal healthcare system. (2021) (0)
- Volumetric modulated arc therapy (VMAT) is superior to intensity modulated radiotherapy (IMRT) for liver sparing in SBRT for hepatocellular carcinoma (2020) (0)
- Market Regulation May Influence Drug Price Trajectories - A Comparison of Anti Tumor Necrosis Factor Drug Prices In Israel And The USA (2016) (0)
- Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma (2017) (0)
- The role of postoperative PET-CT in the evaluation of patients with high-risk stage III colorectal cancer (CRC). (2011) (0)
- PO-0794 Postoperative Chemoradiotherapy in Gastric Cancer with Poor Response to Neoadjuvant Chemotherapy (2019) (0)
- Differences in Toxicity Between Ashkenazi and Sephardic Jews With Colon Cancer Treated With Adjuvant Chemotherapy: A Prospective Study (2022) (0)
- Next Generation Sequencing in Salivary Gland Carcinomas: Do Actionable Mutations Lead to a Therapeutic Advantage? A Multicenter Experience. (2019) (0)
- 1677P Risk factors predicting immune checkpoint inhibitors (ICIs) toxicity using machine learning computer algorithm (2022) (0)
- Association of the addition of cetuximab to preoperative chemoradiotherapy (CRT) for locally advanced esophageal squamous cell carcinoma (SqCC) with rate of long term survival: Mature results of a prospective phase Ib/II trial. (2017) (0)
This paper list is powered by the following services:
Other Resources About Neve Gordon
What Schools Are Affiliated With Neve Gordon?
Neve Gordon is affiliated with the following schools:
